Keisuke Kosai

机构：Kyushu University, National Hospital Organization Kyushu Cancer Center, Kyushu University Hospital · ORCID：0000-0002-2537-9390

发表论文 34 篇 · 总被引 759 次 · h-index 12

代表论文

• The novel driver gene ASAP2 is a potential druggable target in pancreatic cancer (2021 · Cancer Science · 被引 53)
• Interleukin-38 promotes tumor growth through regulation of CD8+ tumor-infiltrating lymphocytes in lung cancer tumor microenvironment (2020 · Cancer Immunology Immunotherapy · 被引 36)
• Prognostic Impact of Albumin-bilirubin (ALBI) Grade on Non-small Lung Cell Carcinoma: A Propensity-score Matched Analysis (2021 · Anticancer Research · 被引 29)
• Impact of the pretreatment prognostic nutritional index on the survival after first‐line immunotherapy in non‐small‐cell lung cancer patients (2023 · Cancer Medicine · 被引 15)
• Convergent genomic diversity and novel BCAA metabolism in intrahepatic cholangiocarcinoma (2023 · British Journal of Cancer · 被引 15)
• Transducin Beta-Like 2 is a Potential Driver Gene that Adapts to Endoplasmic Reticulum Stress to Promote Tumor Growth of Lung Adenocarcinoma (2023 · Annals of Surgical Oncology · 被引 9)